{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T04:34:07Z","timestamp":1791866047883,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"International Science and Technology Cooperation Project of Henan Province of China","award":["42102520016"],"award-info":[{"award-number":["42102520016"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-60785-3","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T08:35:16Z","timestamp":1784622916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Structure\u2013activity relationship studies of febuxostat derivatives identify potent anti-lung cancer agents that induce DNA damage and autophagy"],"prefix":"10.1038","volume":"16","author":[{"given":"Xixi","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"60785_CR1","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1038\/s41380-019-0595-x","volume":"25","author":"YH Wang","year":"2020","unstructured":"Wang, Y. H. et al. Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies. Mol. Psychiatry 25, 1487 (2020).","journal-title":"Mol. Psychiatry"},{"key":"60785_CR2","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-19-3682","volume":"80","author":"IA Prior","year":"2020","unstructured":"Prior, I. A., Hood, F. E. & Hartley, J. L. The frequency of Ras mutations in cancer. Cancer Res. 80, 2969 (2020).","journal-title":"Cancer Res."},{"key":"60785_CR3","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/S2468-2667(23)00186-X","volume":"8","author":"C Xia","year":"2023","unstructured":"Xia, C. et al. Cancer screening in China: A steep road from evidence to implementation. Lancet Public Health 8, 996 (2023).","journal-title":"Lancet Public Health"},{"key":"60785_CR4","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.tips.2023.09.008","volume":"44","author":"G Pedini","year":"2023","unstructured":"Pedini, G., Chen, C. L., Achsel, T. & Bagni, C. Cancer drug repurposing in autism spectrum disorder. Trends Pharmacol. Sci. 44, 963 (2023).","journal-title":"Trends Pharmacol. Sci."},{"key":"60785_CR5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.tips.2025.02.009","volume":"46","author":"KC Wang","year":"2025","unstructured":"Wang, K. C., Zheng, T. & Hubbard, B. P. CRISPR\/Cas technologies for cancer drug discovery and treatment. Trends Pharmacol. Sci. 46, 437 (2025).","journal-title":"Trends Pharmacol. Sci."},{"key":"60785_CR6","first-page":"47","volume":"20","author":"G Schwartsmann","year":"2002","unstructured":"Schwartsmann, G. et al. Anticancer drug discovery and development throughout the world. J. Clin. Oncol. 20, 47 (2002).","journal-title":"J. Clin. Oncol."},{"key":"60785_CR7","doi-asserted-by":"publisher","first-page":"100770","DOI":"10.1016\/j.drup.2021.100770","volume":"57","author":"L Gao","year":"2021","unstructured":"Gao, L., Wu, Z. X., Assaraf, Y. G., Chen, Z. S. & Wang, L. Overcoming anti-cancer drug resistance via restoration of tumor suppressor gene function. Drug Resist. Updates. 57, 100770 (2021).","journal-title":"Drug Resist. Updates"},{"key":"60785_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.semcancer.2019.12.012","volume":"68","author":"A Gonzalez-Fierro","year":"2021","unstructured":"Gonzalez-Fierro, A. & Duenas-Gonzalez, A. Drug repurposing for cancer therapy, easier said than done. Sem. Cancer Biol. 68, 123 (2021).","journal-title":"Sem. Cancer Biol."},{"issue":"1","key":"60785_CR9","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s41392-021-00648-7","volume":"6","author":"R Huang","year":"2021","unstructured":"Huang, R. & Zhou, P. K. DNA damage repair: Historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy. Signal Transduct. Target. Ther. 6254. (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"60785_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","volume":"28","author":"D Kaloni","year":"2023","unstructured":"Kaloni, D., Diepstraten, S. T., Strasser, A. & Kelly, G. L. BCL-2 protein family: Attractive targets for cancer therapy. Apoptosis 28, 20 (2023).","journal-title":"Apoptosis"},{"key":"60785_CR11","doi-asserted-by":"publisher","first-page":"101170","DOI":"10.1016\/j.drup.2024.101170","volume":"78","author":"X Niu","year":"2025","unstructured":"Niu, X. et al. Autophagy in cancer development, immune evasion, and drug resistance. Drug Resist. Updates 78, 101170 (2025).","journal-title":"Drug Resist. Updates"},{"key":"60785_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.trecan.2021.09.004","volume":"8","author":"J Puccini","year":"2022","unstructured":"Puccini, J., Badgley, M. A. & Bar-Sagi, D. Exploiting cancer\u2019s drinking problem: regulation and therapeutic potential of macropinocytosis. Trends Cancer. 8, 54 (2022).","journal-title":"Trends Cancer"},{"key":"60785_CR13","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/s12276-023-00974-6","volume":"55","author":"JY Im","year":"2023","unstructured":"Im, J. Y., Kang, M. J., Kim, B. K. & Won, M. DDIAS, DNA damage-induced apoptosis suppressor, is a potential therapeutic target in cancer. Exp. Mol. Med. 55, 879 (2023).","journal-title":"Exp. Mol. Med."},{"key":"60785_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06154-8","volume":"14","author":"S Liu","year":"2023","unstructured":"Liu, S., Yao, S., Yang, H., Liu, S. & Wang, Y. Autophagy: Regulator of cell death. Cell Death Dis. 14, 648 (2023).","journal-title":"Cell Death Dis."},{"key":"60785_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1021\/ml900022q","volume":"1","author":"T Weide","year":"2010","unstructured":"Weide, T., Saldanha, S. A., Minond, D., Spicer, T. P. & Fokin, V. V. NH-1,2,3-Triazole inhibitors of the VIM-2 metallo-\u03b2-lactamase. ACS Med. Chem. Lett. 1, 150 (2010).","journal-title":"ACS Med. Chem. Lett."},{"key":"60785_CR16","doi-asserted-by":"publisher","first-page":"7788","DOI":"10.1021\/acs.jmedchem.4c00652","volume":"67","author":"Q Guan","year":"2024","unstructured":"Guan, Q. et al. Triazoles in Medicinal Chemistry: Physicochemical Properties, Bioisosterism, and Application. J. Med. Chem. 67, 7788 (2024).","journal-title":"J. Med. Chem."},{"key":"60785_CR17","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1039\/C4MD00031E","volume":"5","author":"XW Ye","year":"2014","unstructured":"Ye, X. W. et al. Synthesis and biological evaluation of coumarin-1,2,3-triazole-dithiocarbamate hybrids as potent LSD1 inhibitors. MedChemComm 5, 650 (2014).","journal-title":"MedChemComm"},{"key":"60785_CR18","doi-asserted-by":"crossref","unstructured":"Kummari, B., Polkam, N., Ramesh, P., Anantaraju, H., Yogeeswari, P., Anireddy, J. S., Guggilapu, S. D., & Babu, B. N. Design and synthesis of 1,2,3-triazole-etodolac hybrids as potent anticancer molecules. RSC. Adv. 7, 23680 (2017).","DOI":"10.1039\/C6RA28525B"},{"key":"60785_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2023.106926","volume":"141","author":"S Zhou","year":"2023","unstructured":"Zhou, S. et al. Discovery of dolutegravir-1,2,3-triazole derivatives against prostate cancer via inducing DNA damage. Bioorg. Chem. 141, 106926 (2023).","journal-title":"Bioorg. Chem."},{"key":"60785_CR20","doi-asserted-by":"publisher","first-page":"8784","DOI":"10.1021\/acs.jmedchem.9b00942","volume":"62","author":"UF Rohrig","year":"2019","unstructured":"Rohrig, U. F. et al. Inhibition mechanisms of indoleamine 2,3-dioxygenase 1 (IDO1). J. Med. Chem. 62, 8784 (2019).","journal-title":"J. Med. Chem."},{"key":"60785_CR21","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1080\/10406638.2025.2467956","volume":"45","author":"B Arun","year":"2025","unstructured":"Arun, B. et al. Rational design and synthesis of 1,2,3-triazole incorporated oxazolo[5,4-d]pyrimidine derivatives: In-vitro cytotoxicity and In-silico moleculardocking simulations. Polycycl. Aromat. Compd. 45, 1515 (2025).","journal-title":"Polycycl. Aromat. Compd."},{"key":"60785_CR22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/10406638.2021.2021256","volume":"43","author":"R Sireesha","year":"2023","unstructured":"Sireesha, R. et al. Synthesis of aryl incorporated oxazolo[4,5-b]pyridine-triazole derivatives: Anticancer evaluation and molecular docking studies. Polycycl. Aromat. Compd. 43, 915 (2023).","journal-title":"Polycycl. Aromat. Compd."},{"key":"60785_CR23","doi-asserted-by":"publisher","first-page":"864","DOI":"10.2174\/1570178617666200225102939","volume":"17","author":"SK Shahinshavali","year":"2020","unstructured":"Shahinshavali, S. K., Poojith, N., Guttikonda, V. R., Sreenivasulu, R. & Rao, M. V. B. Design, synthesis and anticancer evaluation of acetamides comprising 1,2,3-triazole, 1,3,4-thiadiazole and Isothiazolo[4,3-b]pyridine rings. Lett. Org. Chem. 17, 864 (2020).","journal-title":"Lett. Org. Chem."},{"key":"60785_CR24","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1134\/S1070363219080279","volume":"89","author":"IS Murthy","year":"2019","unstructured":"Murthy, I. S., Sreenivasulu, R., Alluraiah, G. & Raju, R. R. Design, synthesis and anticancer activity of 1,2,3-triazole linked 1,2-isoxazole - imidazo[4,5-b]pyridine derivatives. Russ. J. Gen. Chem. 89, 1718 (2019).","journal-title":"Russ. J. Gen. Chem."},{"key":"60785_CR25","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1134\/S1070363219120314","volume":"89","author":"T Yakantham","year":"2019","unstructured":"Yakantham, T. et al. Synthesis and anticancer evaluation of 1,2,3-triazole linked thiazole-1,2-isoxazole derivatives as anticancer agents. Russian J. Gen. Chem. 89, 2522 (2019).","journal-title":"Russian J. Gen. Chem."},{"key":"60785_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2024.107457","volume":"148","author":"LL Han","year":"2024","unstructured":"Han, L. L. et al. Synthesis of triazole AD-1 derivatives and its mechanism of mediating DNA damage of ROS in lung cancer cells. Bioorg. Chem. 148, 107457 (2024).","journal-title":"Bioorg. Chem."},{"key":"60785_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2021.131747","volume":"1250","author":"MS Reddy","year":"2022","unstructured":"Reddy, M. S. et al. Synthesis of fused 1,2,3-triazoles of Clioquinol via sequential CuAAC and C\u2013H arylation; in vitro anticancer activity, in silico DNA topoisomerase II inhibitory activity and ADMET. J. Mol. Struct. 1250, 131747 (2022).","journal-title":"J. Mol. Struct."},{"key":"60785_CR28","doi-asserted-by":"publisher","first-page":"107437","DOI":"10.1016\/j.bioorg.2024.107437","volume":"148","author":"NFM EI Hamaky","year":"2024","unstructured":"EI Hamaky, N. F. M. et al. Novel quinazolin-2-yl 1,2,3-triazole hybrids as promising multi-target anticancer agents: Design, synthesis, and molecular docking study. Bioorg. Chem. 148, 107437 (2024).","journal-title":"Bioorg. Chem."},{"issue":"6","key":"60785_CR29","doi-asserted-by":"publisher","first-page":"e18000101","DOI":"10.1002\/cbdv.201800101","volume":"15","author":"SK Boda","year":"2018","unstructured":"Boda, S. K. et al. 1,2,3-Triazole tagged 3H-pyrano[2,3-d]pyrimidine-6-carboxylate derivatives: Synthesis, in vitro cytotoxicity, molecular docking and DNA interaction studies. Chem. Biodivers. 15e18000101. (2018).","journal-title":"Chem. Biodivers."},{"key":"60785_CR30","doi-asserted-by":"publisher","first-page":"14639","DOI":"10.1007\/s13369-024-09685-0","volume":"50","author":"G Raghavender","year":"2025","unstructured":"Raghavender, G., Chandrasekhar, C. H., Kapavarapu, R. K. & Sreenivasulu, R. Synthesis of amide derivatives of pyrimidine-triazolo[1,5-a]pyridin-7-yl)thiazoles: in vitro anticancer evaluation and in silico molecular binding studies. Arab. J. Sci. Eng. 50, 14639 (2025).","journal-title":"Arab. J. Sci. Eng."},{"key":"60785_CR31","doi-asserted-by":"publisher","first-page":"5368","DOI":"10.1080\/10406638.2021.1939067","volume":"42","author":"CM Bandaru","year":"2022","unstructured":"Bandaru, C. M. et al. Design, synthesis, anticancer evaluation and molecular docking studies of thiazole-pyrimidine linked amide derivatives. Polycycl. Aromat. Compd. 42, 5368 (2022).","journal-title":"Polycycl. Aromat. Compd."},{"key":"60785_CR32","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1007\/s00044-020-02590-9","volume":"29","author":"V Ragha Suma","year":"2020","unstructured":"Ragha Suma, V. et al. Design, synthesis and biological evaluation of chalcone linked thiazole-imidazopyridine derivatives as anticancer agents. Med. Chem. Res. 29, 1643 (2020).","journal-title":"Med. Chem. Res."},{"key":"60785_CR33","doi-asserted-by":"publisher","first-page":"109560","DOI":"10.1016\/j.bioorg.2026.109560","volume":"171","author":"XX Hou","year":"2026","unstructured":"Hou, X. X. et al. Structure-activity relationship and anticancer mechanism of febuxostat-1,2,3-triazole hybrids inducing DNA damage and apoptosis. Bioorg. Chem. 171, 109560 (2026).","journal-title":"Bioorg. Chem."},{"key":"60785_CR34","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1007\/s11696-024-03861-0","volume":"79","author":"ER Devi","year":"2025","unstructured":"Devi, E. R. et al. Design, synthesis, in-vitro and in-silico anticancer studies on amide derivatives of 1,3,4-oxadiazole-isoxazol-pyridine-benzimidazole. Chem. Pap. 79, 1385\u20131405 (2025).","journal-title":"Chem. Pap."},{"key":"60785_CR35","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1080\/00304948.2024.2321004","volume":"56","author":"J Lingam","year":"2024","unstructured":"Lingam, J., Mallavarapu, B. D., Sreenivasulu, R. & Sahoo, B. K. Design, synthesis, anticancer evaluation and molecular docking studies of amide derivatives of 1,3,4-thiadiazolyl pyridinyl isoxazoles. Org. Prep Proced. Int. 56, 486\u2013498 (2024).","journal-title":"Org. Prep Proced. Int."},{"key":"60785_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s00044-020-02638-w","volume":"30","author":"CS Rani","year":"2021","unstructured":"Rani, C. S. et al. Synthesis and anticancer evaluation of amide derivatives of Imidazo-Pyridines as anticancer agents. Med. Chem. Res. 30, 74\u201383 (2021).","journal-title":"Med. Chem. Res."},{"key":"60785_CR37","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s13369-020-04626-z","volume":"46","author":"YZ Pragathi","year":"2021","unstructured":"Pragathi, Y. Z., Sreenivasulu, R., Veronica, D. & Raju, R. R. Design, Synthesis and Biological Evaluation of 1,2,4-thiadiazole-1,2,4-triazole derivatives bearing amide functionality as anticancer agents. Arab. J. Sci. Eng. 46, 225\u2013232 (2021).","journal-title":"Arab. J. Sci. Eng."},{"key":"60785_CR38","first-page":"54","volume":"17","author":"E Ramyadevi","year":"2020","unstructured":"Ramyadevi, E., Sreenivasulu, R., Rao, K. P., Nadh, R. V. & Sireesha, M. Novel 1,3,4 - Thiadiazole linked amide derivatives of Pteridone: Synthesis and study of anticancer activities. Lett. Org. Chem. 17, 54\u201360 (2020).","journal-title":"Lett. Org. Chem."},{"key":"60785_CR39","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1134\/S1070363219030228","volume":"89","author":"VR Suma","year":"2019","unstructured":"Suma, V. R., Sreenivasulu, R., Subramanyam, M. & Rao, K. R. M. Design, synthesis and anticancer evaluation of amide derivatives of structurally modified Combretastatin A4 as anticancer agents. Russian J. Gen. Chem. 89, 499\u2013504 (2019).","journal-title":"Russian J. Gen. Chem."},{"key":"60785_CR40","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1134\/S1070363219020257","volume":"89","author":"SK Shahinshavali","year":"2019","unstructured":"Shahinshavali, S. K., Sreenivasulu, R., Guttikonda, V. R., Kolli, D. & Rao, M. V. B. Synthesis and biological evaluation of amide derivatives of 1,2-isoxazole fused 1,2,4-thiadiazole as anticancer agents. Russian J. Gen. Chem. 89, 324\u2013329 (2019).","journal-title":"Russian J. Gen. Chem."},{"key":"60785_CR41","unstructured":"Watanabe, K., Yarino, T. & Hiramatsu, T. Production of 2-(4-alkoxy-3-cyanophenyl)thiazole derivative: JP, 10045733. 1996-08-01."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60785-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60785-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60785-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:24:47Z","timestamp":1784805887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-60785-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["60785"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-60785-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"23084"}}